Skip to main content

Table 2 Frequency of acute and late Genitourinary (GU) and Gastrointestinal (GI) toxicity

From: Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

   # Resolved
Acute GU:   
 Grade 0 7 (15 %) -
 Grade 1 23 (48 %) 16
 Grade 2 18 (37 %) 17 (1 dose de-escalation)
Acute GI:   
 Grade 0 23 (48 %)  
 Grade 1 20 (42 %) 10
 Grade 2 5 (10 %) 1
Late GU:   
 Grade 0 25 (52 %) -
 Grade 1 10 (21 %) 3
 Grade 2 12 (25 %) 9
 Grade 3 1 (2 %) 1 (Obstruction)
Late GI:   
 Grade 0 42 (87.5 %) -
 Grade 1 6 (12.5 %) 1
  1. Acute Toxicity: Maximum grade observed during the first 6 months from start of protocol therapy